Menorrhagia: Clinical Trials

5 trials for Menorrhagia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Terminated 5

Follow Menorrhagia: new trials by email Literature Review of Menorrhagia trials Research Report on Menorrhagia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Minimize Menorrhagia in Women With Von Willebrand Disease
recombinant von Willebrand factor, tranexamic acid - Von Willebrand Diseases
Phase 3TerminatedMargaret Ragni392019-02-072024-07-01
A Study to Assess the Safety and Efficacy of Vilaprisan in Japanese Subjects With Uterine Fibroids and Heavy Menstrual Bleeding
Vilaprisan (BAY1002670) - Uterine Fibroids and Heavy Menstrual Bleeding
Phase 3TerminatedBayer1532018-03-302022-07-08
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Vilaprisan (BAY1002670), Placebo - Uterine Fibroids
Phase 3TerminatedBayer1032018-01-242022-06-30
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
Vilaprisan (BAY1002670), Placebo - Uterine Fibroids
Phase 3TerminatedBayer932018-01-172023-05-03
The Effect of Post Ablation Medroxyprogesterone Acetate on Endometrial Amenorrhea Rates
MPA, placebo - Menorrhagia
Phase 3TerminatedGuy Waddell602015-08-012022-05-23

Narrower conditions

Leiomyoma (3)  ·  von Willebrand Diseases (1)

Broader conditions

Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Genital Diseases (5)  ·  Genital Diseases, Female (5)  ·  Hemorrhage (5)  ·  Menstruation Disturbances (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Urogenital Diseases (5)  ·  Uterine Diseases (5)  ·  Uterine Hemorrhage (5)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Muscle Tissue (3)

Interventions

vilaprisan (3)  ·  Medroxyprogesterone Acetate (1)  ·  Tranexamic Acid (1)

Sponsors

Bayer (3)  ·  Guy Waddell (1)  ·  Margaret Ragni (1)

Countries

United States (3)  ·  Czechia (2)  ·  Japan (2)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Israel (1)  ·  Malaysia (1)  ·  New Zealand (1)  ·  Russia (1)  ·  Singapore (1)  ·  South Africa (1)  ·  Ukraine (1)

Top investigators

Margaret V Ragni, MD, MPH (1)

Results publications

PMID 37385272, PMID 37437885, PMID 41059527

NIH funding

2016 (1), 2017 (1), U01HL133815 (1)